Sanofi-Aventis Czech Republic's net debt stood at CZK 774 mil and accounted for 103% of equity at the end of 2017. The ratio is up 25.2 pp compared to the previous year.
Historically, the firm’s net debt to equity reached a high of 336% in 2004 and a low of 57.8% in 2015 between 2004 and 2017. The average for the last five years was 89.9%.
Net debt to EBITDA was calculated at 15.3x at the end of the year. That is up from 16.5x seen in 2012. The ratio reached a high of 29.5x in 2004 and a low of 4.16x in 2005.
The company’s cost of funding amounted to 0.748% in 2017, down which is above the 5-year of 0.802%. Funding costs have “eaten” some 13.1% of the operating profit generated in 2019.
You can see all the company’s data at Sanofi-Aventis Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
